%0 Journal Article
%B Circulation
%D 2018
%G eng
%P 660 - 661
%R 10.1161/CIRCULATIONAHA.118.035717
%T Letter by Matthews et al Regarding Article, "Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes: Implications for the Cardiovascular Disease Specialist"
%V 138